Background. A spillover of simian foamy virus (SFV) to humans, following bites from infected nonhuman primates (NHPs), is ongoing in exposed populations. These retroviruses establish persistent infections of unknown physiological consequences to the human host.
et des Libertés, and Comité de protection des personnes Ile de France IV). This study was registered at Clinicaltrials.gov (available at: https://clinicaltrials.gov/ct2/show/NCT03225794/). All participants gave written informed consent.
All participants were Cameroonian men. We previously performed a serological and molecular survey to assess the prevalence of foamy virus infection in people who reported contact with NHPs with a resulting wound [10] . For the present study, cases consisted of individuals who were infected with a gorilla SFV; all were recruited from participants of our former survey. Twenty-four of 33 potentially eligible participants [10] were present in their village at the time of the visit of the medical team and agreed to participate in the study. Other eligible participants had died or moved away. Each case was matched individually for age (±10 years) and ethnicity to 1 SFV-uninfected control, recruited from hunters who participated in the same survey and who lived in same or neighboring villages as cases [10] .
SFV infection was defined by positive results of both Western blots (defined as detection of the p70-p74 Gag doublet) and polymerase chain reaction assays (defined as detection of the gene encoding integrase and/or the associated long terminal repeat) performed at the time of the epidemiological survey [10] . Results of SFV diagnostic tests were confirmed at least twice to be positive or negative. Anti-hepatitis B virus (HBV) core antibodies and HBV surface antigen were assessed with the Monolisa kits (catalog numbers 72315 and 72346; Bio-Rad, Marnes-La-Coquette, France). Immunoblot assays were used for the diagnosis of HIV-1 and HTLV-1/2 infection (LAV Blot1; catalog No. 72251, Biorad and HTLV Blot 2.4, MP Diagnostics). One HIV-1-infected control was excluded, and no case was infected with HIV-1. Ten cases and 3 controls were infected with HTLV-1.
Clinical and Biological Evaluations
A complete clinical examination by a board-certified physician was performed for each case and control at the Centre Pasteur du Cameroun (CPC), in Yaoundé. Blood tests were performed by the medical analysis laboratory at the CPC and are listed in Supplementary Table 1 . In addition, blood specimens from 24 participants (12 cases and 12 age-and ethnicity-matched controls) were collected into tubes containing ethylenediaminetetraacetic acid. Plasma was isolated and stored at −80°C. Protein electrophoresis was performed by the Laboratoire de Biologie Médicale Volontaires-Cerballiance in Paris. Ferritin, transferrin, soluble transferrin receptor, haptoglobin, erythropoietin, hepcidin, C-reactive protein, interleukin 6, and interleukin 18 binding protein A levels were quantified by enzyme-linked immunosorbent assay (Supplementary Table 2 ).
Statistical Analysis
Logistic regression was performed to study differences in clinical signs between cases and controls. The levels of blood and plasma parameters were treated as quantitative variables, and the paired Wilcoxon signed-rank test was used to compare cases and controls. We used the Fisher exact test to compare frequencies of cases and controls with values outside the normal range, based on sex-specific reference values used in Cameroon (Supplementary  Table 1 ). We used logistic regression to study the effect of confounders (HTLV-1 infection and sampling during the rainy season) on the associations between blood parameters and SFV infection status, with blood parameters transformed into binary variables (based on whether the value was below versus above the median value). We studied associations between hemoglobin levels and plasma biomarkers with the Spearman rank test. Data were analyzed with Stata 12.1 software (StataCorp).
RESULTS

Frequencies of Clinical Signs do not Differ Between Cases and Controls
Cases and controls were bush-meat hunters who reported injuries, mostly bites inflicted during hunting activities (Table 1) . Ages ranged from 22 to 67 years. All participants in the study were apparently healthy at the time of the analysis. We performed a complete clinical examination of all study participants. Overall, 65% had at least 1 clinical sign, and 42% had at least 2 clinical signs. General and cutaneous signs were each observed in 38% of participants; high blood pressure, in 31%; other cardiorespiratory signs, in 29%; gastrointestinal signs, in 21%; and neurologic signs, in 8%. Cases and controls had similar frequencies of clinical signs, whether considered individually, by affected organ, or globally (Table 2) .
Cases Had Lower Hemoglobin Levels Than Controls
Blood counts were performed for all participants (Table 3) . Cases had significantly lower levels of hemoglobin than controls (median values, 12.7 g/dL in cases and 14.4 g/dL in controls; P = .01). The hematocrit was significantly lower in cases than controls (median, 37 vs 42%; P = .009). Erythrocyte counts were similar in cases and controls (4.2 × 10 3 cells/µL and 4.6 × 10 3 cells/µL, respectively; P = .14). Furthermore, cases had a lower mean corpuscular volume (88 vs 92 fL; P = .03) and mean corpuscular hemoglobin level (29.7 vs 31.1 pg; P = .03) than controls despite a similar mean corpuscular hemoglobin concentration (34.2% and 34.0%, respectively; P = .36).
Cases had significantly lower median basophil counts (20 vs 46 cells/µL; P = .03) and percentages (0.3% vs 0.7%; P = .01) than controls. Other leukocyte counts and proportions were similar between the 2 groups (Table 3 ). Eosinophilia, defined as an eosinophil count >0.6 × 10 3 cells/µL, occurred in 42 of 48 participants. One case had a very high eosinophil count (9.4 × 10 3 cells/µL), and 1 case and 1 control had neutrophil to lymphocyte ratios >2.5.
Levels of Several Biochemical Parameters Differed Between Cases and Controls
Blood tests were performed to explore biochemical markers of the principal functions of the liver, kidneys, and blood. Cases had significantly higher median levels of urea (median, 0.31 vs 0.23 g/L; P = .01), creatinine (10.0 vs 9.0 mg/L; P = .05), protein (88 vs. 78 g/L; P = .05), creatine phosphokinase (117 vs 64 IU/L; P = .02), and lactate dehydrogenase (751 vs 637 IU/L; P = .03) than controls, whereas their total bilirubin levels were significantly lower (5.0 vs 10.6 mg/mL; P = .002). There were no differences in the levels of electrolytes, glycemia, hepatic, or pancreatic markers between cases and controls (Table 3) .
Hematological Parameters and SFV Infection: No Obvious Effect of Coinfection With Other Pathogens
Within each ethnic group, all participants had similar living environments, occupations, modes of subsistence, and dietary habits. Most were probably chronic carriers of several pathogens. The possible confounding factors considered were common chronic viral infections (ie, HTLV-1 and HBV infection) and the rainy season, during which carriage of parasites, including malaria parasites, increases, with possible effects on hematological and biochemical parameters.
HTLV-1 can be transmitted from NHPs to humans through bites [21] . In this study, 10 cases and 3 controls were infected with HTLV-1 (42% and 13%, respectively; adjusted odds ratio, 5.00 [95% confidence interval, 1.17-21.46]; P = .03). Adjustment for HTLV-1 infection did not modify the associations observed in univariate analyses, except that the association with lactate dehydrogenase level was slightly weaker and that with MCV was slightly stronger (Figure 1 ). Among cases, HTLV-1 infection was associated with a higher MCV (Supplementary Table 3 ) and may have diminished the association between a lower MCV and SFV infection. All but 1 participant was positive for anti-HBV core antibody, and 2 cases were positive for HBV surface antigen, ruling out HBV coinfection as a major bias in this study. Collection and analysis of blood was performed during the rainy season (AugustOctober) for one third of participants (ie, 9 cases and 7 controls). Adjustment for sampling period did not modify the associations observed in univariate analyses ( Figure 1 ). None of the participants had clinical signs of malaria at sampling. Most importantly, cases had lower bilirubin levels than controls, indicating that parasitic hemolysis was unlikely to be responsible for the lower hemoglobin levels observed. In conclusion, hematological differences between cases and controls were probably not affected by coinfection with pathogens commonly found in the studied population.
Relevance of Observed Differences
We performed additional analyses to investigate whether differences in blood markers between cases and controls could be medically relevant. First, we compared the frequencies of people in each group who had values outside of the normal range (reference ranges for men in Cameroon are presented in Supplementary Table 1) . We observed significant differences between cases and controls for hemoglobin (<13.4 g/dL: 67% vs 17%, respectively; P = .001), bilirubin (>15 mg/L: 0% and 29%, respectively; P = .009), and protein (>85 g/L: 54% and 21%, respectively; P = .04) levels and basophil counts (<10 cells/ µL: 42% and 4%, respectively; P = .004). We also observed mild anemia, according to the World Health Organization threshold (defined as a hemoglobin level of <13 g/dL), in 58% of cases and 17% of controls (P = .007). Three cases and 1 control had moderate anemia (defined as <11 g/dL), and no participant had severe anemia (<8 g/dL). The power of the statistical analyses was calculated for variables that differed significantly between cases and controls, with Figure 1 . Lack of impact of confounders on differences in hematological parameters between cases and controls. Separate logistic analyses were performed for the 11 blood parameters associated with simian foamy virus infection. Blood parameter levels were transformed into binary variables (based on whether the value was below versus above the median value). Results are presented as adjusted odds ratios (aORs) and 95% confidence intervals (CIs). The results from univariate analysis performed on the whole group are shown in black; those from multivariate analysis, including human T lymphotropic virus type 1 (HTLV-1) infection, are shown in dark grey; and those from multivariate analysis, including the rainy season, are shown in light grey. CPK, creatine phosphokinase; LDH, lactate dehydrogenase; MCH, mean corpuscular hemoglobin; MCV, mean corpuscular volume.
an α of 0.05 for a 2-sided test (Supplementary Table 4 ). The power of the tests performed for hematocrit and for hemoglobin, urea, and bilirubin levels were >0.85, and the power of the test performed for lactate dehydrogenase level was >0.70. We repeated the case-control analysis for participants aged <65 years, to exclude an age-related effect on the observed differences, and obtained results similar to those for the entire group (data not shown). Importantly, cases had still significantly lower hemoglobin levels than controls (median, 12.6 vs 14.4 g/dL; P < .01).
For the 24 cases, the estimated duration of infection negatively correlated with total bilirubin levels (Spearman rho = −0.459; P = .02). However, bilirubin levels tended to negatively correlate with age, as well (Spearman rho = −0.375; P = .07). Blood SFV DNA levels were quantified for 23 cases [10] and did not correlate with hemoglobin, bilirubin, protein, or basophil levels (Supplementary Figure 1) .
Cases Had Higher Gamma Globulin and Lower Transferrin Levels Than Controls
Blood tests and blood sampling for the biobank were performed on the same day for 12 cases, providing an opportunity to quantify additional biomarkers (Table 4) . We selected 12 controls, matched for age and ethnicity. Gamma globulin levels were significantly higher in cases than controls (median, 25.0 vs 21.1 g/L; P = .004), as were beta-2 globulin levels (9.5 vs 8.8 g/L; P = .045). Transferrin levels were significantly lower in cases than in controls (median, 3.3 vs 3.6 g/L; P = .049). The powers of analyses were >0.80 and >0.90 for gamma globulin and transferrin levels, respectively (Supplementary Table 4 ). The levels of other plasma globulins, iron status-related molecules, and inflammatory markers did not differ significantly between cases and controls.
DISCUSSION
Foamy viruses were first recognized as a distinct subfamily among retroviruses almost 30 years ago [22] . Foamy viruses have been reported to be nonpathogenic, with rare exceptions in animal studies [23] [24] [25] . The search for associated diseases after isolation of a foamy virus from a human sample in 1971 led to conflicting results, most likely due to the lack of specificity of diagnostic assays [13, 26, 27] . Over the last 20 years, the assessment of infection in humans has been performed using validated diagnostic assays, and zoonotic transmission of SFV has been firmly demonstrated [12, 13, 28] . In our study, the infection status was established by the detection of both plasma SFV-specific antibodies and SFV DNA in blood cells. Having identified a series of SFV-infected humans in South Cameroon, we set up a case-control study investigating key human physiological functions. Cases and controls consisted of men who reported NHP-inflicted injuries during hunting, lived in the same or neighboring villages of South Cameroon, and were matched for age and ethnicity. We selected individuals infected with gorilla SFV, because this host-specific viral clade was the most frequently found among Central African hunters and because of the phylogenetic relatedness between humans and apes. There was no statistical association between clinical signs and SFV infection. However, levels of hemoglobin, basophils, urea, creatinine, protein, creatine phosphokinase, bilirubin, and lactate dehydrogenase differed significantly between cases and controls. One of these observations may be medically significant: 11 of 24 individuals infected with SFV had mild anemia (hemoglobin level, <13 g/dL), and 3 had moderate anemia (<11 g/dL). Our results raise several questions, including whether the differences between cases and controls are a consequence of SFV infection and, if so, what the underlying mechanism is for these di fferences, as well as how to evaluate the clinical implications of our findings in SFV-infected humans.
The critical issue regarding the identification of biological markers that differ between SFV-infected and noninfected hunters is whether they are a consequence of SFV infection or another health-related factor. We performed a case-control study because it is the best-adapted method to study rare diseases with a long incubation period. We carefully considered selection biases during the recruitment of controls. Indeed, cases and controls shared high-risk exposure to NHP body fluids that are a source of SFV, and their SFV infections status was unknown at the time of inclusion in the initial epidemiological survey. For the present study, controls were matched to cases on the basis of age, ethnicity, and geographical proximity. Nevertheless, the statistical association between hemoglobin levels and SFV infection should be interpreted with caution because of the high rate of possible concurrent infections and comorbidities in the study population and because hemoglobin levels are affected by multiple factors. The aim of this study was to search for medical features associated with SFV infection and not to define the causes of an a priori unknown condition. Thus, we can only check for the absence of obvious causes of reduced hemoglobin levels. There was no evidence of chronic bleeding (ie, soluble transferrin receptor and ferritin values were normal, transferrin levels were low, and bleeding was not observed during clinical examination) or hemolysis (ie, bilirubin levels did not increase, and haptoglobin levels did not decrease). Some parasitic infections decrease hemoglobin levels by lysing red blood cells. However, cases had low levels of both hemoglobin and bilirubin, arguing against parasite-induced hemolysis. We found no differences in eosinophil levels between cases and controls, and the inclusion of rainy season as a confounder did not modify the statistical associations between blood parameters and SFV infection status (Figure 1 ). These results are consistent with adequate matching of cases and controls for environmental antigens. An alternative explanation for the low hemoglobin levels observed in cases is that genetic polymorphisms associated with hemoglobin synthesis also control susceptibility to SFV infection. Such polymorphisms are highly prevalent in Africa and affect the susceptibility to infection by several Plasmodium species and viruses, including HIV-1, or their severity [29] [30] [31] .
Our preliminary data suggest 2 possible mechanisms by which SFV infection could cause anemia: inflammation and/or reduced red blood cell production. Anemia related to chronic disease is supported by low transferrin levels and high gamma globulin levels in cases and could be explained by the persistence of immune stimulation, because SFV is a potent inducer of type I interferon production in vitro [32] . Plasma soluble transferrin receptor levels, a marker of erythropoiesis, were similar for cases and controls, supporting a defect in red blood cell production. SFV infection of erythroid progenitors is a possible mechanism to account for lower levels of red blood cell production in cases. Furthermore, the prototype foamy virus of chimpanzee origin replicates in erythroblastoid cells [33] . Foamy virus can be recovered from most organs of infected animals [34] . Foamy virus DNA has been detected in bone marrow from infected monkeys [35] and cattle [36] but not cats [24] . The following retroviruses cause anemia by infecting cells of the erythroid lineage: feline leukemia virus [37] , avian erythroblastosis virus [38] , and Friend ecotropic murine leukemia virus [39] . Hemoglobin levels did not correlate with SFV DNA levels in blood cells. Such a correlation would have supported an effect of SFV infection on hemoglobin levels. However, the lack of such an association may reflect that the level of SFV DNA in blood cells is not an appropriate marker of SFV replication, owing to its ubiquitous cell and organ tropism [26] , in contrast to HIV-1 and HTLV-1, for which the major target is CD4 + T lymphocytes.
The clinical implications of our study for SFV-infected individuals are globally reassuring. One limitation of this study was the enrollment of apparently healthy individuals, which reduced the ability to detect potential cases of acute and/or severe SFV-associated disease. In addition, identifying symptoms associated with a chronic retroviral infection is challenging: for people infected with HIV-1 and HTLV-1, symptoms appear after year-long or decade-long incubation periods, are diverse, and affect only a fraction of infected individuals. This was a particular challenge in our study population, which came from rural areas and was of a low socioeconomic status, with limited access to healthcare, and which exhibited multiple clinical signs. Alcohol and tobacco consumption were frequent and not significantly different between cases and controls (data not shown). However, medications were rarely reported by participants in the study. In conclusion, we did not identify clinical signs specific to cases, but our results do not rule out the existence of pathological consequences of SFV infection, because we only studied apparently healthy individuals.
The low prevalence of SFV infection and logistical challenges of such field studies are major obstacles to the replication of our results. The number of participants was also limited. Nevertheless, the power of analysis was >0.85 for 4 variables (hemoglobin, hematocrit, bilirubin, and urea levels). Recruiting 2 controls per case would still not have provided sufficient power to strengthen the conclusions for the other variables (Supplementary Table 4 ). These limitations are inherent to the situations in which SFV is transmitted to humans: ape bites are infrequent, and exposed hunters live in areas in which local healthcare structures are very modest and cannot provide medical or virological follow-up for such infections. In Western countries, blood tests have been performed for 7 SFV-infected individuals living in the United States, and no erythrocyte or hemoglobin values were reported to be out of the normal range [20] . However, the 7 individuals studied were infected with different SFV strains (chimpanzee and baboons) and were of different genetic background than those of our study population. Also, there was no control group. Thus, whether the hematological changes observed in gorilla SFV-infected individuals from Central Africa are due to infection with a SFV from a different NHP species, differences in living conditions, and/or differences in ethnic origin remains unknown.
Several future studies based on our results are possible to establish the potential medical relevance of low hemoglobin levels and other hematological changes. First, the generic physical examination and blood tests initially performed in our study population could be repeated with the addition of anemia-specific investigations (eg, determination of reticulocyte counts, diagnostic testing for malaria parasites, and analysis of stool specimens for the presence of blood) and the assessment of comorbidities (eg, poor nutritional status and enteropathies). The prevalence of SFV infection could be investigated in specific groups, such as patients displaying clinical signs or anemia, in the context of a systematic hospital-based survey. Immunosuppressed individuals, specifically those infected with HIV-1, merit careful analysis, because coinfection with both retroviruses has been described in humans [40, 41] and because SFV worsen the consequences of simian immunodeficiency virus infection in macaques [25, 42] . Studies in animals infected with foamy viruses may allow the testing of some hypotheses, although pathogenesis may differ between natural and nonnatural hosts.
In conclusion, the exposure of humans to SFV is ongoing worldwide, mostly in Central Africa, Asia, and South America. Our findings in Central African hunters may have implications for infected individuals. Further studies are warranted in other SFV-infected populations.
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